CFAM
Center For Asset Management’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $909K | Buy |
34,395
+16,252
| +90% | +$429K | 0.56% | 42 |
|
2025
Q1 | $460K | Sell |
18,143
-16,909
| -48% | -$428K | 0.28% | 77 |
|
2024
Q4 | $930K | Buy |
35,052
+1,243
| +4% | +$33K | 0.6% | 39 |
|
2024
Q3 | $978K | Buy |
33,809
+550
| +2% | +$15.9K | 0.58% | 42 |
|
2024
Q2 | $931K | Buy |
33,259
+990
| +3% | +$27.7K | 0.62% | 38 |
|
2024
Q1 | $895K | Sell |
32,269
-944
| -3% | -$26.2K | 0.73% | 30 |
|
2023
Q4 | $956K | Sell |
33,213
-2,513
| -7% | -$72.3K | 0.87% | 27 |
|
2023
Q3 | $1.19M | Buy |
35,726
+1,698
| +5% | +$56.3K | 1.18% | 21 |
|
2023
Q2 | $1.25M | Buy |
34,028
+10,134
| +42% | +$372K | 1.18% | 20 |
|
2023
Q1 | $975K | Buy |
23,894
+5,228
| +28% | +$213K | 0.95% | 22 |
|
2022
Q4 | $956K | Buy |
18,666
+3,902
| +26% | +$200K | 0.89% | 28 |
|
2022
Q3 | $646K | Buy |
14,764
+1,407
| +11% | +$61.6K | 0.64% | 37 |
|
2022
Q2 | $700K | Sell |
13,357
-1,482
| -10% | -$77.7K | 0.65% | 36 |
|
2022
Q1 | $768K | Buy |
14,839
+3,899
| +36% | +$202K | 0.59% | 36 |
|
2021
Q4 | $646K | Buy |
10,940
+2,125
| +24% | +$125K | 0.48% | 45 |
|
2021
Q3 | $379K | Sell |
8,815
-586
| -6% | -$25.2K | 0.32% | 57 |
|
2021
Q2 | $368K | Buy |
9,401
+1,790
| +24% | +$70.1K | 0.32% | 58 |
|
2021
Q1 | $276K | Buy |
7,611
+431
| +6% | +$15.6K | 0.26% | 67 |
|
2020
Q4 | $264K | Buy |
+7,180
| New | +$264K | 0.26% | 66 |
|